Review article: The need for more efficient and patient-oriented drug development pathways in NASH-setting the scene for platform trials.
Aliment Pharmacol Ther
; 57(9): 948-961, 2023 05.
Article
in En
| MEDLINE
| ID: mdl-36918740
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Non-alcoholic Fatty Liver Disease
Type of study:
Clinical_trials
/
Guideline
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Aliment Pharmacol Ther
Journal subject:
FARMACOLOGIA
/
GASTROENTEROLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: